Trump is still very excited about hydroxychloroquine


At Sunday night's Fox News virtual town hall, President Trump said he still talks a lot about the malaria drug hydroxychloroquine as a COVID-19 treatment and complained that some Democrats "would rather see people — I'm going to be very nice, I'm not going to say die — I'm going to say would rather see people not get well because they think I'm going to get credit if, you know, hydroxychloroquine works." He dismissed a Veterans Affairs study suggesting the drug increased the risk of death and a subsequent FDA warning.
In his quest for a "silver bullet" to slay the coronavirus, Trump became obsessed with hydroxychloroquine after hearing frequent praise for the drug from Fox News and friends, The Washington Post reported Saturday night. "Although Trump stopped touting the drug publicly, privately he maintained his support for hydroxychloroquine and got upset with government officials presenting studies or bringing him evidence of its risks or failings, encouraging them to have a more positive outlook." Fox News host Laura Ingraham brought two doctors to the Oval Office on April 3 to talk up the malaria drug, the Post reports, adding this anecdote:
Keith Frankel, a vitamins executive who occasionally socializes with Trump at his Mar-a-Lago Club in Palm Beach, Fla., said the president asked him to call California Gov. Gavin Newsom (D) on his cellphone and try to make a deal for the nation's largest state to buy millions of tablets of hydroxychloroquine from an Indian manufacturer. Frankel said he got Newsom's phone number from Trump. ... "A guy I know sells products to these guys in India who are making the drug," Frankel said. He said he learned of the Indian manufacturer through a connection in Turkey. Several million of the pills could have been supplied, he said, but "there ended up being no deal." [The Washington Post]
Top U.S. medical officials are more excited about Remdesivir, and Trump also touted that experimental antiviral drug in the Fox News town hall. "We are putting the full power and might behind this drug," he said, without elaborating.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
What does 'conquering' Gaza mean to Israel?
Today's Big Question Benjamin Netanyahu's cabinet has approved a plan to displace much of the Palestinian population while seizing and occupying the territory on a long-term basis.
-
Casey Means: the controversial 'wellness influencer' nominated for surgeon general
In the Spotlight Means has drawn controversy for her closeness to RFK Jr.
-
Trump taps Fox News' Pirro for DC attorney post
speed read The president has named Fox News host Jeanine Pirro to be the top federal prosecutor for Washington, replacing acting US Attorney Ed Martin
-
Warren Buffet announces surprise retirement
speed read At the annual meeting of Berkshire Hathaway, the billionaire investor named Vice Chairman Greg Abel his replacement
-
Trump calls Amazon's Bezos over tariff display
Speed Read The president was not happy with reports that Amazon would list the added cost from tariffs alongside product prices
-
Markets notch worst quarter in years as new tariffs loom
Speed Read The S&P 500 is on track for its worst month since 2022 as investors brace for Trump's tariffs
-
Tesla Cybertrucks recalled over dislodging panels
Speed Read Almost every Cybertruck in the US has been recalled over a stainless steel panel that could fall off
-
Crafting emporium Joann is going out of business
Speed Read The 82-year-old fabric and crafts store will be closing all 800 of its stores
-
Trump's China tariffs start after Canada, Mexico pauses
Speed Read The president paused his tariffs on America's closest neighbors after speaking to their leaders, but his import tax on Chinese goods has taken effect
-
Chinese AI chatbot's rise slams US tech stocks
Speed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
-
US port strike averted with tentative labor deal
Speed Read The strike could have shut down major ports from Texas to Maine